Ching Chen
Impact in
- Immunology top 5%
- T-cell and B-cell Immunology
- Nephrology top 2%
- Parathyroid Disorders and Treatments
Papers in
-
- Systemic Lupus Erythematosus Research 9
-
- T-cell and B-cell Immunology 8
- Co-authors
- Eline T. Luning Prak (3 shared papers)MARTIN G. WEIGERT (5 shared papers)Zoltán Á. Nagy (2 shared papers)Martin Weigert (1 shared paper)Marko Z. Radic (3 shared papers)Dennis Huszar (1 shared paper)Sally Ann Camper (1 shared paper)Richard R. Hardy (1 shared paper)
- Journals
- The Journal of Immunology (8 papers)Immunity (2 papers)Blood (1 paper)Journal of Clinical Investigation (1 paper)Schizophrenia Bulletin (1 paper)
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Ching Chen
33 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 83
- Immunology 686
- Nephrology 336
- Rheumatology 405
- Orthopedics and Sports Medicine 115
- Virology 34
Countries citing papers authored by Ching Chen
This map shows the geographic impact of Ching Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching Chen more than expected).
Fields of papers citing papers by Ching Chen
This network shows the impact of papers produced by Ching Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching Chen. The network helps show where Ching Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ching Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 367 | |
| 2 | 2012 | 339 | |
| 3 | 1995 | 264 | |
| 4 | 1995 | 249 | |
| 5 | 1997 | 187 | |
| 6 | Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties. | 2003 | 158 |
| 7 | 2008 | 134 | |
| 8 | 2001 | 111 | |
| 9 | 2012 | 78 | |
| 10 | 2020 | 47 | |
| 11 | 2012 | 44 | |
| 12 | 2012 | 43 | |
| 13 | 2015 | 41 | |
| 14 | 2013 | 39 | |
| 15 | 2012 | 32 | |
| 16 | 2006 | 31 | |
| 17 | 2013 | 31 | |
| 18 | 2019 | 28 | |
| 19 | Development of an ICOSL and BAFF bispecific inhibitor AMG 570 for systemic lupus erythematosus treatment. | 2019 | 26 |
| 20 | 2015 | 25 |
About Ching Chen
Ching Chen is a scholar working on Rheumatology, Immunology, Hematology, Radiology, Nuclear Medicine and Imaging and Psychiatry and Mental health, having authored 33 papers that have together received 2.4k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (9 papers), T-cell and B-cell Immunology (8 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Schizophrenia research and treatment (3 papers), Acute Myeloid Leukemia Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Fibroblast Growth Factor Research (2 papers) and Nematode management and characterization studies (1 paper). The work is most often cited by research in Immunology (686 citations), Nephrology (336 citations), Rheumatology (405 citations), Orthopedics and Sports Medicine (115 citations) and Virology (34 citations). Ching Chen has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Eline T. Luning Prak, MARTIN G. WEIGERT, Zoltán Á. Nagy, Martin Weigert, Marko Z. Radic, Dennis Huszar, Sally Ann Camper, Richard R. Hardy, Jennitte L. Stevens and Nessa Hawkins. Their work appears in journals such as The Journal of Immunology, Immunity, Blood, Journal of Clinical Investigation and Schizophrenia Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.